Frontline therapy for newly diagnosed patients with multiple myeloma

Since the introduction of an alkylator to the treatment of multiple myeloma (MM), new effective agents have been developed, such as immunomodulatory drugs including thalidomide, lenalidomide, and pomalidomide; proteasome inhibitors including bortezomib, carfilzomib, and ixazomib; monoclonal antibodi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Res
Hoofdauteurs: Jung, Sung-Hoon, Jo, Jae-Cheol, Song, Ga-Young, Ahn, Seo-Yeon, Yang, Deok-Hwan, Ahn, Jae-Sook, Kim, Hyeoung-Joon, Lee, Je-Jung
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2020
Onderwerpen:
Review Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7386893/
https://ncbi.nlm.nih.gov/pubmed/32719175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2020.S007
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items